|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 9/00 | |
| A61K 38/14 | |||
| A61P 31/04 |
| (11) | Number of the document | 1292611 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01932807.9 |
| Date of filing the European patent application | 2001-05-01 | |
| (97) | Date of publication of the European application | 2003-03-19 |
| (45) | Date of publication and mention of the grant of the patent | 2008-03-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2001/013996 |
| Date | 2001-05-01 |
| (87) | Number | WO 2001/098327 |
| Date | 2001-12-27 |
| (30) | Number | Date | Country code |
| 213417 P | 2000-06-22 | US |
| (72) |
LINSELL, Martin, S., US
FATHEREE, Paul, R., US
JUDICE, J., Kevin, US
LEADBETTER, Michael, R., US
ZHU, Yan, US
|
| (73) |
Theravance, Inc.,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (54) | GLYCOPEPTIDE CARBOXY-SACCHARIDE DERIVATIVES |
| GLYCOPEPTIDE CARBOXY-SACCHARIDE DERIVATIVES |